ALZN
Price
$2.49
Change
+$0.16 (+6.87%)
Updated
Oct 24 closing price
Capitalization
9.47M
Intraday Buy/Sell Signals
INMB
Price
$1.90
Change
+$0.11 (+6.15%)
Updated
Oct 24 closing price
Capitalization
50.51M
5 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ALZN vs INMB

Header iconALZN vs INMB Comparison
Open Charts ALZN vs INMBBanner chart's image
Alzamend Neuro
Price$2.49
Change+$0.16 (+6.87%)
Volume$199.13K
Capitalization9.47M
INmune Bio
Price$1.90
Change+$0.11 (+6.15%)
Volume$345.51K
Capitalization50.51M
ALZN vs INMB Comparison Chart in %
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. INMB commentary
Oct 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a StrongBuy and INMB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 25, 2025
Stock price -- (ALZN: $2.49 vs. INMB: $1.90)
Brand notoriety: ALZN and INMB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 166% vs. INMB: 58%
Market capitalization -- ALZN: $9.47M vs. INMB: $50.51M
ALZN [@Biotechnology] is valued at $9.47M. INMB’s [@Biotechnology] market capitalization is $50.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 0 FA rating(s) are green whileINMB’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 0 green, 5 red.
  • INMB’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALZN and INMB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 6 TA indicator(s) are bullish while INMB’s TA Score has 6 bullish TA indicator(s).

  • ALZN’s TA Score: 6 bullish, 3 bearish.
  • INMB’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, INMB is a better buy in the short-term than ALZN.

Price Growth

ALZN (@Biotechnology) experienced а +12.16% price change this week, while INMB (@Biotechnology) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Reported Earning Dates

INMB is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMB($50.5M) has a higher market cap than ALZN($9.47M). INMB YTD gains are higher at: -59.315 vs. ALZN (-76.149). ALZN has higher annual earnings (EBITDA): -6.17M vs. INMB (-39.72M). INMB has more cash in the bank: 33.4M vs. ALZN (5.62M). ALZN has less debt than INMB: ALZN (301K) vs INMB (451K). INMB has higher revenues than ALZN: INMB (50K) vs ALZN (0).
ALZNINMBALZN / INMB
Capitalization9.47M50.5M19%
EBITDA-6.17M-39.72M16%
Gain YTD-76.149-59.315128%
P/E RatioN/AN/A-
Revenue050K-
Total Cash5.62M33.4M17%
Total Debt301K451K67%
FUNDAMENTALS RATINGS
INMB: Fundamental Ratings
INMB
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNINMB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KOSS5.190.15
+2.98%
Koss Corp
RYTM110.471.35
+1.24%
Rhythm Pharmaceuticals
SITIF3.63N/A
N/A
SITC International Holdings Company, Ltd.
ZEUS29.35-0.02
-0.07%
Olympic Steel
CEPU9.45-0.12
-1.25%
Central Puerto SA

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+6.87%
SRPT - ALZN
49%
Loosely correlated
+4.20%
VRAX - ALZN
46%
Loosely correlated
-0.83%
SNSE - ALZN
41%
Loosely correlated
+0.96%
ASBP - ALZN
41%
Loosely correlated
+2.47%
BPMUF - ALZN
36%
Loosely correlated
N/A
More